Terms: = Ovarian cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
14 results:
1. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract] [Full Text] [Related]
2. Genetic medicine is accelerating in Japan.
Hayashi S; Kubo M; Kaneshiro K; Kai M; Yamada M; Morisaki T; Takao Y; Shimazaki A; Shikada S; Nakamura M
Breast Cancer; 2022 Jul; 29(4):659-665. PubMed ID: 35191009
[TBL] [Abstract] [Full Text] [Related]
3. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
[TBL] [Abstract] [Full Text] [Related]
5. Predictors of survival trajectories among women with epithelial ovarian cancer.
Peres LC; Sinha S; Townsend MK; Fridley BL; Karlan BY; Lutgendorf SK; Shinn E; Sood AK; Tworoger SS
Gynecol Oncol; 2020 Feb; 156(2):459-466. PubMed ID: 31839342
[TBL] [Abstract] [Full Text] [Related]
6. cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to diagnosis data, 2006-2015.
Herbert A; Abel GA; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G
Br J Gen Pract; 2019 Oct; 69(687):e724-e730. PubMed ID: 31455644
[TBL] [Abstract] [Full Text] [Related]
7. External validation of the paediatric risk of malignancy index.
Hermans AJ; Kluivers KB; Massuger LF; Coppus SF
BJOG; 2016 Feb; 123(3):448-52. PubMed ID: 25559216
[TBL] [Abstract] [Full Text] [Related]
8. Trends of vulvar cancer.
Chhabra S; Bhavani M; Deshpande A
J Obstet Gynaecol; 2014 Feb; 34(2):165-8. PubMed ID: 24456439
[TBL] [Abstract] [Full Text] [Related]
9. Persistent ovarian masses and pregnancy outcomes.
Goh WA; Rincon M; Bohrer J; Tolosa JE; Sohaey R; Riaño R; Davis J; Zalud I
J Matern Fetal Neonatal Med; 2013 Jul; 26(11):1090-3. PubMed ID: 23356452
[TBL] [Abstract] [Full Text] [Related]
10. Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer: a case--control study.
Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(9):4695-8. PubMed ID: 23167404
[TBL] [Abstract] [Full Text] [Related]
11. Sexually transmissible infections and prostate cancer risk.
Huang WY; Hayes R; Pfeiffer R; Viscidi RP; Lee FK; Wang YF; Reding D; Whitby D; Papp JR; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2374-81. PubMed ID: 18768506
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
[TBL] [Abstract] [Full Text] [Related]
13. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract] [Full Text] [Related]
14. The completeness and accuracy of health authority and cancer registry records according to a study of ovarian neoplasms.
Mukherjee AK; Leck I; Langley FA; Ashcroft C
Public Health; 1991 Jan; 105(1):69-78. PubMed ID: 2008506
[TBL] [Abstract] [Full Text] [Related]
